Search research articles
Contact Us
Filters
Showing results (91-100 of 187) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2015
Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression
Jiyoon Lee, Salvatore Condello, Bakhtiyor Yakubov, et al.
Molecular Cancer Therapeutics
|
June 16, 2012
Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer
Minghai Shao, Stacy Hollar, Daphne Chambliss, et al.
Nature Communications
|
August 5, 2022
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
Yuying Tan, Junjie Li, Guangyuan Zhao, et al.
Journal of Clinical Medicine
|
November 9, 2024
Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography
Rareș Crăciun, Alina Buliarcă, Daniela Matei, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 4, 2026
Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients
Elnaz Abbasi Farid, Shu Zhang, Zhen Fu, et al.
Journal of Clinical Medicine
|
August 27, 2021
Hepatic Hydrothorax-An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
Daniela Matei, Rares Craciun, Dana Crisan, et al.
Gynecologic Oncology
|
April 1, 2014
MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer
John K Chan, Tuyen K Kiet, Kevin Blansit, et al.
Neoplasia (New York, N.Y.)
|
October 30, 2016
Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer
Jiyoon Lee, Bakhtiyor Yakubov, Cristina Ivan, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis
Daniela Matei, Ioana Buculei, Catalina Luca, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients
Elnaz Abbasi Farid, Shu Zhang, Zhen Fu, et al.
Page
of 19
Search research articles
Search
Showing results (91-100 of 187) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2015
Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression
Jiyoon Lee, Salvatore Condello, Bakhtiyor Yakubov, et al.
Molecular Cancer Therapeutics
|
June 16, 2012
Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer
Minghai Shao, Stacy Hollar, Daphne Chambliss, et al.
Nature Communications
|
August 5, 2022
Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells
Yuying Tan, Junjie Li, Guangyuan Zhao, et al.
Journal of Clinical Medicine
|
November 9, 2024
Cirrhosis Progression Is Not Associated with Clinically Significant Alterations in Global Hemostasis Assessed by Thromboelastography
Rareș Crăciun, Alina Buliarcă, Daniela Matei, et al.
Pharmaceuticals (Basel, Switzerland)
|
May 4, 2026
Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients
Elnaz Abbasi Farid, Shu Zhang, Zhen Fu, et al.
Journal of Clinical Medicine
|
August 27, 2021
Hepatic Hydrothorax-An Independent Decompensating Event Associated with Long-Term Mortality in Patients with Cirrhosis
Daniela Matei, Rares Craciun, Dana Crisan, et al.
Gynecologic Oncology
|
April 1, 2014
MiR-378 as a biomarker for response to anti-angiogenic treatment in ovarian cancer
John K Chan, Tuyen K Kiet, Kevin Blansit, et al.
Neoplasia (New York, N.Y.)
|
October 30, 2016
Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer
Jiyoon Lee, Bakhtiyor Yakubov, Cristina Ivan, et al.
International Journal of Molecular Sciences
|
August 26, 2022
Impact of Non-Pharmacological Interventions on the Mechanisms of Atherosclerosis
Daniela Matei, Ioana Buculei, Catalina Luca, et al.
Biorxiv : the Preprint Server for Biology
|
February 27, 2026
Effects of the Hypomethylating Agent Guadecitabine on Peripheral Blood Mononuclear Cell Methylomes and Immune Cell Populations in Small-Cell Lung Cancer Patients
Elnaz Abbasi Farid, Shu Zhang, Zhen Fu, et al.
Page
of 19